Saint Francis Heart Hospital
6161 S Yale Ave, 
Tulsa, OK 

Overview

Gregory Kirkpatrick is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma.

His clinical expertise encompasses Hereditary Spherocytosis, Desmoid Tumor, Burkitt Lymphoma, and Acute Lymphoblastic Leukemia (ALL).

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 13 clinical trials. Dr. Kirkpatrick is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in OK

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CommunityCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Saint Francis Heart Hospital
6161 S Yale Ave, Tulsa, OK 74136

Additional Areas of Focus

Dr. Kirkpatrick has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Umbrella Long-Term Follow-Up Protocol
View 7 Less Clinical Trials
Similar Doctors
Expertise in
45
conditions
Hematology | Oncology
Expertise in
45
conditions
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (4.0 miles away)
Languages Spoken:
English, Arabic
Accepting New Patients

Jihad Khattab is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Khattab is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Khattab is currently accepting new patients.

Expertise in
48
conditions
Hematology | Oncology
Expertise in
48
conditions
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (4.0 miles away)
Languages Spoken:
English, Urdu
Accepting New Patients
Offers Telehealth

Muhammad Janjua is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Janjua is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Familial Pancreatic Cancer, Aplastic Anemia, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Aspiration. Dr. Janjua is currently accepting new patients.

Expertise in
28
conditions
Hematology | Oncology
Expertise in
28
conditions
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (4.0 miles away)
Languages Spoken:
English
Accepting New Patients

Matthew Armstrong is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Armstrong is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Armstrong is currently accepting new patients.

Frequently Asked Questions about Dr. Gregory G. Kirkpatrick

How do I make an appointment with Dr. Gregory G. Kirkpatrick?

You can book an appointment with Dr. Gregory G. Kirkpatrick by calling their office at 918-502-6720. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gregory G. Kirkpatrick a top-rated expert for Hereditary Spherocytosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory G. Kirkpatrick is classified as an Experienced expert for Hereditary Spherocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gregory G. Kirkpatrick specialize in?

While Dr. Gregory G. Kirkpatrick is a Hematology, they have specific expertise in Hereditary Spherocytosis, Desmoid Tumor, and Burkitt Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Gregory G. Kirkpatrick participate in research or clinical trials?

Yes. Dr. Gregory G. Kirkpatrick has published 1 articles and abstracts on conditions like Hereditary Spherocytosis. You can view a list of Dr. Gregory G. Kirkpatrick's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gregory G. Kirkpatrick accept my insurance?

Dr. Gregory G. Kirkpatrick accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 918-502-6720 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kirkpatrick's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile